Neuroectodermal Tumors, Primitive
Showing 9976 - 10000 of >10,000
Refractory Cancer Trial in Seoul
Unknown status
- Refractory Cancer
-
Seoul, Gyunggido, Korea, Republic ofSamsung Medical Center
Aug 27, 2013
Stage IV Cancer Patients
Unknown status
- Stage IV Cancer (Solid Tumors Only)
- Survival
-
Yang Ling, Shaanxi, ChinaYang Ling Demonstration Zone Hospital
Apr 27, 2013
Carcinoma Breast Trial in Milan (external fractionated radiotherapy, intraoperative radiotherapy)
Completed
- Carcinoma Breast
- external fractionated radiotherapy
- intraoperative radiotherapy
-
Milan, ItalyEuropean Institute of Oncology
May 5, 2013
Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor Trial in Worldwide (Everolimus 10 mg, Octreotide Depot)
Completed
- Islet Cell Carcinoma
- +3 more
- Everolimus 10 mg
- Octreotide Depot
-
Birmingham, Alabama
- +53 more
May 6, 2013
Tumor, Metastatic Trial in Rochester (MRI with breath-holding)
Terminated
- Neoplasm, Metastatic
- MRI with breath-holding
-
Rochester, New YorkUniversity of Rochester Department of Radiation Oncology
Apr 18, 2013
Solid Tumor Trial in Madison (triapine, irinotecan HCl, laboratory biomarker analysis)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- triapine
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
May 15, 2013
Solid Tumor Trial in Madison (triapine, doxorubicin HCl, laboratory biomarker analysis)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- triapine
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
May 15, 2013
Bone Mineral Density in Survivors of Solid Pediatric Cancers
Completed
- Osteoporosis
-
Syracuse, New YorkSUNY Upstate Medical University
May 29, 2013
Hepatocellular Carcinoma Trial in Worldwide (PR104 550 mg/m^2 + sorafenib, PR104 770 mg/m^2 + sorafenib)
Terminated
- Hepatocellular Carcinoma
- PR104 550 mg/m^2 + sorafenib
- PR104 770 mg/m^2 + sorafenib
-
Tucson, Arizona
- +16 more
Jul 19, 2013
Colorectal Cancer Trial in Stanford (FOLFOX regimen, fluorouracil, gefitinib)
Completed
- Colorectal Cancer
- FOLFOX regimen
- +4 more
-
Stanford, CaliforniaStanford Cancer Center at Stanford University Medical Center
May 14, 2013
Brain and CNS Tumors, Lymphoma, Child Solid Tumor Trial in United States (filgrastim, exatecan mesylate)
Completed
- Brain and Central Nervous System Tumors
- +2 more
- filgrastim
- exatecan mesylate
-
New York, New York
- +3 more
May 15, 2012
Gastrointestinal Stromal Tumors Trial in Philadelphia (Nilotinib)
Terminated
- Gastrointestinal Stromal Tumors
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 15, 2013
Solid Tumor Trial in Philadelphia (carboplatin, gemcitabine HCl)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- carboplatin
- gemcitabine hydrochloride
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 16, 2013
Recurrent Melanoma, Recurrent Renal Cell Cancer, Stage IV Melanoma Trial in Philadelphia (bryostatin 1, temsirolimus)
Completed
- Recurrent Melanoma
- +4 more
- bryostatin 1
- temsirolimus
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
May 1, 2013
Cancer Trial in Spain, United States (XL765 (SAR245409))
Completed
- Cancer
- XL765 (SAR245409)
-
Detroit, Michigan
- +3 more
May 29, 2013
Child Solid Tumor Trial in Canada, United States (carboplatin, irinotecan HCl)
Completed
- Unspecified Childhood Solid Tumor, Protocol Specific
- carboplatin
- irinotecan hydrochloride
-
Tucson, Arizona
- +6 more
Apr 3, 2013
Cancer Trial in Kashiwa-shi (BMS-833923 (XL139))
Completed
- Cancer
- BMS-833923 (XL139)
-
Kashiwa-shi, Chiba, JapanLocal Institution
May 31, 2013
Nuclear Factor Kappa-B Polymorphism and Organ Injury After
Completed
- Single Nucleotide Polymorphism
- +2 more
-
Shanghai, ChinaChanghai Hospital, Second Military Medical University
May 2, 2013
Solid Tumor Trial in Philadelphia (irinotecan HCl, raltitrexed)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- irinotecan hydrochloride
- raltitrexed
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 16, 2013
Advanced Solid Tumors, Multiple Myeloma Trial in United States (ACE-041)
Completed
- Advanced Solid Tumors
- Multiple Myeloma
- ACE-041
-
Scottsdale, Arizona
- +3 more
Mar 14, 2013
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Terminated
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +59 more
- tanespimycin
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
May 15, 2013
Squamous Cell Carcinoma of Head and Neck Trial in Maywood, Boston (ZD6474, Docetaxel)
Completed
- Squamous Cell Carcinoma of Head and Neck
-
Maywood, Illinois
- +2 more
Jul 1, 2013